,panitumumab,bevacizumab,trastuzumab deruxtecan
astrazeneca,amgen,takeda,daiichi sankyo,roche
['mbc', 'breast', 'destinybreast04', 'paradigm']
well done #myeloma rt : #asco22 #plenarysession summary 1. #destinybreast04: tdxd in low her2 mbc
2. #paradigm: pan + mfolfox6 vs bev + mf 
Washington U. School of Medicine.
Assoc Director Hem/Onc Fellowship.
Myeloma, Amyloidosis, Leukemia, Lymphoma & BMT physician and researcher.
Tweets are my own.